Yeah there is something fishy here. There is ample evidence of anti competitive behaviour. TM/LN are well known in the industry as being bullies. This should be a slam dunk case for someone who really wanted to chase it.
The resale market at minimum should be separated, if not the ticketing from the touring side.
I trust they considered the bias in medical research that exists in their training. I wonder if OpenAI will implement morbidity & mortality (M&M) rounds to learn from the mistakes and missed diagnosis.
Based on the reports of various failings on the safety front, I sure hope users will take that into account before they get advice to take 500g of aspirin.
I’m a happy bidet owner who retrofitted one. The biggest challenge was understanding local regulations and product design when it came to backflow prevention.